Skip to main content
Top
Published in: Cancer Causes & Control 4/2005

01-05-2005

Occupational risks for uveal melanoma results from a case-control study in nine European countries

Authors: Jean-Michel Lutz, Ian Cree, Svend Sabroe, Tine Kajsa Kvist, Lene Bjørk Clausen, Noemia Afonso, Wolfgang Ahrens, Terri J. Ballard, Janine Bell, Diane Cyr, Mikael Eriksson, Joëlle Févotte, Pascal Guénel, Lennart Hardell, Karl-Heinz Jöckel, Ana Miranda, Franco Merletti, Maria M. Morales-Suarez-Varela, Aivars Stengrevics, Elsebeth Lynge

Published in: Cancer Causes & Control | Issue 4/2005

Login to get access
Metadata
Title
Occupational risks for uveal melanoma results from a case-control study in nine European countries
Authors
Jean-Michel Lutz
Ian Cree
Svend Sabroe
Tine Kajsa Kvist
Lene Bjørk Clausen
Noemia Afonso
Wolfgang Ahrens
Terri J. Ballard
Janine Bell
Diane Cyr
Mikael Eriksson
Joëlle Févotte
Pascal Guénel
Lennart Hardell
Karl-Heinz Jöckel
Ana Miranda
Franco Merletti
Maria M. Morales-Suarez-Varela
Aivars Stengrevics
Elsebeth Lynge
Publication date
01-05-2005
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2005
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-004-5029-6

Other articles of this Issue 4/2005

Cancer Causes & Control 4/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine